A detailed history of Unified Investment Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Unified Investment Management holds 15,401 shares of NVO stock, worth $746,332. This represents 0.85% of its overall portfolio holdings.

Number of Shares
15,401
Previous 10,025 53.63%
Holding current value
$746,332
Previous $692 Million 23.51%
% of portfolio
0.85%
Previous 0.74%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025

BUY
$45.38 - $71.7 $243,962 - $385,459
5,376 Added 53.63%
15,401 $855 Million
Q2 2025

Jul 15, 2025

BUY
$58.08 - $81.05 $582,252 - $812,526
10,025 New
10,025 $692 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Unified Investment Management Portfolio

Follow Unified Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unified Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Unified Investment Management with notifications on news.